Loading…
Offering priced at-the-market under Nasdaq rules.
Phio Pharmaceuticals Corp. (PHIO) announced a $1.83 million registered direct offering. The offering was priced at-the-market in accordance with Nasdaq rules.
The total amount raised in the offering was $1.83 million.
The company has a free float of 5,677,000 shares.
This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.